Terms: = Lung cancer AND ER, estrogen receptor
1932 results:
1. 25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERβ/TNFRSF17 axis.
He M; Jiang W; Li X; Liu H; Ren H; Lin Y
BMC Cancer; 2024 Apr; 24(1):505. PubMed ID: 38649856
[TBL] [Abstract] [Full Text] [Related]
2. [Non-primary solid malignancies of breast in needle core biopsy: a clinicopathological analysis of 23 cases].
Gu WQ; Wang L; Xu JC; Ping GQ; Han X; Wang C
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):331-336. PubMed ID: 38556815
[No Abstract] [Full Text] [Related]
3. Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.
Du T; Gu Q; Zhang Y; Gan Y; Liang R; Yang W; Lu Y; Xu C; Wu J; Ma R; Cao H; Jiang J; Wang J; Feng J
Cell Commun Signal; 2024 Mar; 22(1):195. PubMed ID: 38539203
[TBL] [Abstract] [Full Text] [Related]
4. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
[TBL] [Abstract] [Full Text] [Related]
5. XAF1 overexpression inhibits the malignant progression and cisplatin resistance of NSCLC by activating endoplasmic reticulum stress.
Chen B; Cheng Y; Wu H; Yao J
Mol Biol Rep; 2024 Mar; 51(1):435. PubMed ID: 38520543
[TBL] [Abstract] [Full Text] [Related]
6. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways.
Ni L; Zhu X; Zhao Q; Shen Y; Tao L; Zhang J; Lin H; Zhuge W; Cho YC; Cui R; Zhu W
Neoplasia; 2024 May; 51():100991. PubMed ID: 38507887
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
8. Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.
Moon JW; Hong BJ; Kim SK; Park MS; Lee H; Lee J; Kim MY
Cancer Lett; 2024 Apr; 588():216781. PubMed ID: 38494150
[TBL] [Abstract] [Full Text] [Related]
9. Purinergic signaling promotes premature senescence.
Volonte D; Benson CJ; Daugherty SL; Beckel JM; Trebak M; Galbiati F
J Biol Chem; 2024 Apr; 300(4):107145. PubMed ID: 38460941
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
[TBL] [Abstract] [Full Text] [Related]
11. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
12. A versatile upconversion-based multimode lateral flow platform for rapid and ultrasensitive detection of microRNA towards health monitoring.
Chen C; Hu S; Tian L; Qi M; Chang Z; Li L; Wang L; Dong B
Biosens Bioelectron; 2024 May; 252():116135. PubMed ID: 38387230
[TBL] [Abstract] [Full Text] [Related]
13. G protein-coupled estrogen receptor activates PI3K/AKT/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis.
Chen J; Zhao R; Wang Y; Xiao H; Lin W; Diao M; He S; Mei P; Liao Y
Mol Med; 2024 Feb; 30(1):28. PubMed ID: 38383297
[TBL] [Abstract] [Full Text] [Related]
14. Combination of Polygonatum Rhizoma and Scutellaria baicalensis triggers apoptosis through downregulation of PON
Liu H; Yue L; Li Y; Zheng T; Zhang W; Li C; Zhuang W; Fan L
Environ Toxicol; 2024 May; 39(5):3172-3187. PubMed ID: 38348599
[TBL] [Abstract] [Full Text] [Related]
15. G-protein-coupled estrogen receptor 1 promotes peritoneal metastasis of gastric cancer through nicotinamide adenine dinucleotide kinase 1-mediated redox modulation.
Wu T; Ding K; Wang C; Lin G; Xie C; Chen X; Li Q; Yu F; Mao Y; Hong W; Lu L; Li S
FASEB J; 2024 Feb; 38(3):e23449. PubMed ID: 38315451
[TBL] [Abstract] [Full Text] [Related]
16. Anti-collagenase, Anti-elastase, Anti-urease, and Anti-cancer Potentials of Isokaempferide as Natural Compound: In vitro and in silico Study.
Yin Q; Zhang H; Huang T; Liu B; Negm S; El-Kott AF
J Oleo Sci; 2024; 73(2):187-199. PubMed ID: 38311409
[TBL] [Abstract] [Full Text] [Related]
17. [A Case of Complete Remission in a Patient with Synchronous Double cancers of the Breast and lung].
Hayakawa T; Hasegawa K; Maejima K; Takatsuno Y; Kaneko J; Higashi Y; Isogai J; Tagawa K; Yoshida H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1459-1461. PubMed ID: 38303307
[TBL] [Abstract] [Full Text] [Related]
18. [A Case of Combined Use of Mohs Paste and Radiation Therapy for Advanced Breast cancer with Bleeding].
Yanagawa T; Yamaura M; Nomura H; Oshima K; Katsuyama S; Shinke G; Kinoshita M; Ikeshima R; Hiraki M; Ohmura Y; Sugimura K; Masuzawa T; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1839-1841. PubMed ID: 38303225
[TBL] [Abstract] [Full Text] [Related]
19. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
20. Edge roughness quantifies impact of physician variation on training and performance of deep learning auto-segmentation models for the esophagus.
Yan Y; Kehayias C; He J; Aerts HJWL; Fitzgerald KJ; Kann BH; Kozono DE; Guthier CV; Mak RH
Sci Rep; 2024 Jan; 14(1):2536. PubMed ID: 38291051
[TBL] [Abstract] [Full Text] [Related]
[Next]
